The Brandon BioCatalyst collaboration is innovation in action: We partner with the best researchers and clinicians, providing capital and hands-on expertise to support the translation of their discoveries from the laboratory to the patient.
Our venture capital model is unique. We don’t simply provide investment, we provide ‘boots on the ground’ support and put in place the necessary infrastructure to enable founders and entrepreneurs to focus on developing and commercialising their technologies, thereby maximising their chance of success.
If you are interested in accessing Brandon BioCatalyst investment for your opportunity, please contact the commercialisation office at your institute.
Brandon BioCatalyst invests exclusively in opportunities that are associated with our Member Institutes.
Through Brandon BioCatalyst, we have created an ecosystem that supports portfolio companies and personnel at all stages of the development cycle.
In addition to the support and resources that Brandon Capital provides, we also ensure integration amongst members and portfolio companies so they’re able to collaborate with one another, sharing resources, networks and expertise, while progressing through the commercialisation process.
With assistance from Brandon Capital, an opportunity seeking funding submits a Preliminary Investment Proposal (PIP) to the Investment Review Committee (IRC).
If this initial PIP is recommended to progress by the IRC, the research and/or management team will be invited to present to the IRC and at the same time will need to submit an Investment Application Form (assisted by Brandon Capital).
If the IRC is supportive of the technology receiving investment, the opportunity is passed to Brandon Capital for due dilligence.
Following detailed due dilligence, if Brandon Capital approves an investment, it recommends to the Board that the investment be made and capital is called. The Board facilitate the calling of capital.
Through the internship it was fantastic to understand what Brandon are looking for in the projects they fund. The learnings from the internship program will be applied to the new projects we develop, both in reviewing the opportunity and developing a solid business plan that will increase the commercial success.
The internship was a valuable experience that filled a critical gap in my knowledge of how early-stage life science technologies are commercialised. Up to this point, my experience was from a technology development perspective, and I did not have a full understanding of what investors were seeking in potential investments. The internship experience is immeasurable and will pay dividends well into the future.
The internship was an excellent learning and development opportunity. I greatly improved my understanding of the venture capital financing model and elements such as valuation, due diligence, market analysis and drug development. The MRCF internship program also enabled me to expand my national commercialisation networks and work alongside experienced biotech investors.